Podcasts about slavea chankova

There is a worrying amount of fraud in medical research. As many as one in 50 research papers may be unreliable because of fabrication, plagiarism or serious errors. Fabricated data can influence the guidelines which doctors use to treat patients. Misguided clinical guidelines could cause serious illness and death in patients. Fraudulent studies can also influence further research programmes—recent findings suggest that manipulated images may have resulted in scientists wasting time and money following blind alleys in Alzheimer's research for decades. What can be done to combat scientific malpractice? Dorothy Bishop, a retired professor of psychology at the University of Oxford, explores the motivation behind fraudsters in research. John Carlisle, an anaesthetist and an editor of the journal Anaesthesia, explains the impact of fraud and how to detect it in research papers. Also, Elisabeth Bik, a former microbiologist and a full-time scientific image detective, discusses the consequences of whistle-blowing on both sleuths and the fraudsters. Plus, The Economist's health-care correspondent, Slavea Chankova, investigates how to overcome the worrying unwillingness on all sides to do anything about fraud in research. Alok Jha hosts.For full access to The Economist's print, digital and audio editions subscribe at economist.com/podcastoffer and sign up for our weekly science newsletter at economist.com/simplyscience. Hosted on Acast. See acast.com/privacy for more information.

There is a worrying amount of fraud in medical research. As many as one in 50 research papers may be unreliable because of fabrication, plagiarism or serious errors. Fabricated data can influence the guidelines which doctors use to treat patients. Misguided clinical guidelines could cause serious illness and death in patients. Fraudulent studies can also influence further research programmes—recent findings suggest that manipulated images may have resulted in scientists wasting time and money following blind alleys in Alzheimer's research for decades. What can be done to combat scientific malpractice? Dorothy Bishop, a retired professor of psychology at the University of Oxford, explores the motivation behind fraudsters in research. John Carlisle, an anaesthetist and an editor of the journal Anaesthesia, explains the impact of fraud and how to detect it in research papers. Also, Elisabeth Bik, a former microbiologist and a full-time scientific image detective, discusses the consequences of whistle-blowing on both sleuths and the fraudsters. Plus, The Economist's health-care correspondent, Slavea Chankova, investigates how to overcome the worrying unwillingness on all sides to do anything about fraud in research. Alok Jha hosts.For full access to The Economist's print, digital and audio editions subscribe at economist.com/podcastoffer and sign up for our weekly science newsletter at economist.com/simplyscience. Hosted on Acast. See acast.com/privacy for more information.

Over the past 18 months, the largest-ever recorded avian influenza outbreak has decimated bird populations around the world. But recently bird flu has spread to mammals. Last week, Peru reported the deaths of 585 sea lions. If the virus has mutated to enable mammal-to-mammal transmission, that could be an intermediate step towards human-to-human transmission. How worrying is this threat?Susan Davies, CEO of the Scottish Seabird Centre, describes how the H5N1 avian flu has affected populations of wild birds. Ian Brown of Britain's Animal and Plant Health Agency explains why the dynamics of this outbreak are concerning scientists. Plus, we ask Marion Koopmans, head of viroscience at Erasmus MC, why she's more worried than ever about a human influenza pandemic. The Economist's Slavea Chankova also compares the influenza threat to the covid-19 pandemic. Do we have enough tools in our arsenal? Alok Jha hosts. For full access to The Economist's print, digital and audio editions subscribe at economist.com/podcastoffer and sign up for our weekly science newsletter at economist.com/simplyscience. Hosted on Acast. See acast.com/privacy for more information.

Over the past 18 months, the largest-ever recorded avian influenza outbreak has decimated bird populations around the world. But recently bird flu has spread to mammals. Last week, Peru reported the deaths of 585 sea lions. If the virus has mutated to enable mammal-to-mammal transmission, that could be an intermediate step towards human-to-human transmission. How worrying is this threat?Susan Davies, CEO of the Scottish Seabird Centre, describes how the H5N1 avian flu has affected populations of wild birds. Ian Brown of Britain's Animal and Plant Health Agency explains why the dynamics of this outbreak are concerning scientists. Plus, we ask Marion Koopmans, head of viroscience at Erasmus MC, why she's more worried than ever about a human influenza pandemic. The Economist's Slavea Chankova also compares the influenza threat to the covid-19 pandemic. Do we have enough tools in our arsenal? Alok Jha hosts. For full access to The Economist's print, digital and audio editions subscribe at economist.com/podcastoffer and sign up for our weekly science newsletter at economist.com/simplyscience. Hosted on Acast. See acast.com/privacy for more information.

Digital tools and sophisticated wearable devices are being combined with the latest knowledge on metabolic science to build personalised eating plans. Slavea Chankova, The Economist's health-care correspondent, explores the future of nutrition. Data from new nutrition technology can also be tied to exercise monitoring devices and blood biomarkers, to build algorithms that aim to make people get healthier. But can the emerging personalised nutrition era make a real difference to public health? Alok Jha hosts.Listen to our recent collection of episodes on the digital health revolution at economist.com/babbagewearables.For full access to The Economist's print, digital and audio editions subscribe at economist.com/podcastoffer and sign up for our weekly science newsletter at economist.com/simplyscience. See acast.com/privacy for privacy and opt-out information.

Digital tools and sophisticated wearable devices are being combined with the latest knowledge on metabolic science to build personalised eating plans. Slavea Chankova, The Economist's health-care correspondent, explores the future of nutrition. Data from new nutrition technology can also be tied to exercise monitoring devices and blood biomarkers, to build algorithms that aim to make people get healthier. But can the emerging personalised nutrition era make a real difference to public health? Alok Jha hosts.Listen to our recent collection of episodes on the digital health revolution at economist.com/babbagewearables.For full access to The Economist's print, digital and audio editions subscribe at economist.com/podcastoffer and sign up for our weekly science newsletter at economist.com/simplyscience. See acast.com/privacy for privacy and opt-out information.

In wealthy and well-vaccinated countries, year three of the pandemic will be better than year two. But in countries that are poorer, less well vaccinated or both, the deleterious effects of the virus will linger. A disparity of outcomes between rich and poor countries will emerge. Meanwhile, tests and treatments for “long covid” are on the horizon and the mRNA technology used in some covid vaccines could be applied to other diseases. So could there be a “covid dividend”?Host Tom Standage talks to The Economist's Edward Carr, Natasha Loder and Slavea Chankova.For full access to print, digital and audio editions, subscribe to The Economist at www.economist.com/podcastoffer.And we would love to hear from you—please take a moment to complete our listener survey at economist.com/worldaheadsurvey. See acast.com/privacy for privacy and opt-out information.

In wealthy and well-vaccinated countries, year three of the pandemic will be better than year two. But in countries that are poorer, less well vaccinated or both, the deleterious effects of the virus will linger. A disparity of outcomes between rich and poor countries will emerge. Meanwhile, tests and treatments for “long covid” are on the horizon and the mRNA technology used in some covid vaccines could be applied to other diseases. So could there be a “covid dividend”?Host Tom Standage talks to The Economist's Edward Carr, Natasha Loder and Slavea Chankova.For full access to print, digital and audio editions, subscribe to The Economist at www.economist.com/podcastoffer.And we would love to hear from you—please take a moment to complete our listener survey at economist.com/worldaheadsurvey. See acast.com/privacy for privacy and opt-out information.

Vaccinations have helped ease national lockdowns, but restrictions on international travel remain severe. When and how might they be lifted?Willie Walsh of the International Air Transport Association tells us airlines are a soft target for government restrictions. Aerosol physicist Lidia Morawska assesses how risky it is to travel by plane. The Economist's Miki Kobayashi reports on July's Tokyo Olympics.Alok Jha and Slavea Chankova are joined by Edward Carr, The Economist's deputy editor.For full access to The Economist's print, digital and audio editions subscribe at economist.com/thejabpod. Sign up for our new weekly science and data newsletters at economist.com/simplyscience and economist.com/offthecharts See acast.com/privacy for privacy and opt-out information.

The Jab: What’s the best vaccination strategy?Getting vaccine regimens right is a matter of life and death. We investigate new research that could shape how jabs are rolled out.The Oxford Vaccine Group’s Matthew Snape says mixing vaccines could boost immunity, and Zeke Emanuel of the University of Pennsylvania explains why second doses should be delayed. Also, we ask Leana Wen of George Washington University whether children should be offered the vaccine.Alok Jha and Natasha Loder are joined by Slavea Chankova, The Economist’s health-care correspondent.For full access to The Economist’s print, digital and audio editions subscribe at economist.com/thejabpod. Sign up for our new weekly science and data newsletters at economist.com/simplyscience and economist.com/offthecharts See acast.com/privacy for privacy and opt-out information.

Photo:  Main illustration for the short story "The Man Who Lived." Internal Illustration from the pulp magazine Weird Tales (September 1941, vol. 36, no. 1).CBS Eye on the World with John BatchelorCBS Audio Network@Batchelorshow1/2: The grim estimates of of the virus deaths worldwide so far. Slavea Chankova @TheEconomisthttps://www.economist.com/leaders/2021/05/15/ten-million-reasons-to-vaccinate-the-world?utm_medium=pr&utm_source=us-e

Photo:  Master of the Death of Absalom.CBS Eye on the World with John BatchelorCBS Audio Network@Batchelorshow2/2: The grim estimates of of the virus deaths worldwide so far. Slavea Chankova @TheEconomisthttps://www.economist.com/leaders/2021/05/15/ten-million-reasons-to-vaccinate-the-world?utm_medium=pr&utm_source=us-e

More than a billion vaccines have been administered. But the contrast between Israel, largely free of covid-19, and India, struggling with a catastrophic second wave, is stark. What explains the discrepancy? Devi Sridhar, Founding Director of the Global Health Governance Programme, tells us what to expect as the next billion vaccines roll out. Alok Jha and Natasha Loder are joined by Slavea Chankova, The Economist’s health-care correspondent, and technology correspondent Hal Hodson. Anshel Pfeffer reports from Israel.For full access to The Economist’s print, digital and audio editions subscribe at economist.com/thejabpod. Sign up for our new weekly science and data newsletters at economist.com/simplyscience and economist.com/offthecharts See acast.com/privacy for privacy and opt-out information.

Large scale covid-19 vaccine trials have taken place at exceptional speed with unprecedented scrutiny. How do they work? And why are the results so politically charged? We speak to Andrew Catchpole, lead scientist on the first trial to infect volunteers with the virus intentionally. Jason Palmer, presenter of The Intelligence, assists in a trial. Alok Jha, The Economist's science correspondent, hosts with our health policy editor, Natasha Loder. Slavea Chankova, The Economist's health-care correspondent, and James Fransham, from our data team, join them.For full access to The Economist’s print, digital and audio editions subscribe at economist.com/thejabpod. Sign up for our new weekly science newsletter at economist.com/simplyscience and data newsletter at economist.com/offthecharts See acast.com/privacy for privacy and opt-out information.

Three vaccines have been approved by stringent regulators. Ten are being used in one or more countries. How do they work and are they effective enough against new variants of the coronavirus?Sarah Gilbert, inventor of the Oxford/Astrazeneca vaccine, tells us adapting to new variants should be easy. The Economist’s Beijing bureau chief David Rennie reports from China, which faces a huge test of its homegrown vaccine technology as it tries to re-open. James Fransham from our data team on how far the variants have spread.Alok Jha, The Economist's science correspondent, hosts with our health policy editor, Natasha Loder. Slavea Chankova, The Economist's health-care correspondent, joins them.For full access to The Economist’s print, digital and audio editions subscribe at economist.com/thejabpod and sign up for our new weekly science newsletter at economist.com/simplyscience See acast.com/privacy for privacy and opt-out information.

“Promises made, promises kept” is one of President Trump’s campaign slogans. His main achievements on tax, deregulation, or appointing new judges would be hallmarks of any Republican administration. How has Donald Trump changed the country in ways no other president would have? What will linger even if he loses?  Adam Roberts, The Economist’s Midwest correspondent, looks at the president’s record on immigration. Trade and globalisation editor Soumaya Keynes tells us how effective Trump’s trade policy has been. And healthcare correspondent Slavea Chankova assesses his response to covid-19. John Prideaux, The Economist's US editor, hosts with New York bureau chief Charlotte Howard, and Jon Fasman, Washington correspondent.1843 Magazine: Movie Night at the White HouseFor access to The Economist’s print, digital and audio editions subscribe: economist.com/2020electionpod  See acast.com/privacy for privacy and opt-out information.

“Promises made, promises kept” is one of President Trump’s campaign slogans. His main achievements on tax, deregulation, or appointing new judges would be hallmarks of any Republican administration. How has Donald Trump changed the country in ways no other president would have? What will linger even if he loses? Adam Roberts, The Economist’s Midwest correspondent, looks at the president’s record on immigration. Trade and globalisation editor Soumaya Keynes tells us how effective Trump’s trade policy has been. And healthcare correspondent Slavea Chankova assesses his response to covid-19. John Prideaux, The Economist's US editor, hosts with New York bureau chief Charlotte Howard, and Jon Fasman, Washington correspondent.1843 Magazine: Movie Night at the White HouseFor access to The Economist’s print, digital and audio editions subscribe: economist.com/2020electionpod See acast.com/privacy for privacy and opt-out information.

Slavea Chankova and Kenneth Cukier investigate the ways in which SARS-CoV-2, the virus which causes covid-19, wears the body down. Apart from pneumonia, there are other facets to the disease that are less understood such as damage to the kidneys, blood vessels and heart. And, how does covid-19 continue to harm the body—and patients' mental health— in the long term?Please subscribe to The Economist for full access to print, digital and audio editions:www.economist.com/podcastoffer See acast.com/privacy for privacy and opt-out information.

Slavea Chankova and Kenneth Cukier investigate the ways in which SARS-CoV-2, the virus which causes covid-19, wears the body down. Apart from pneumonia, there are other facets to the disease that are less understood such as damage to the kidneys, blood vessels and heart. And, how does covid-19 continue to harm the body—and patients' mental health— in the long term?Please subscribe to The Economist for full access to print, digital and audio editions:www.economist.com/podcastoffer See acast.com/privacy for privacy and opt-out information.

President Trump changed tone and course this week, extending federal guidelines on social distancing to the end of April. New York is now the epicentre of the global pandemic. Yet large parts of the US remain relatively unaffected by covid-19. Public opinion supports tough measures to contain the virus for now. But how sustainable are strict curbs on personal freedom in a country founded on individual liberty?The Economist’s healthcare correspondent Slavea Chankova explains the epidemiological models behind the lockdown, we tell the story of history’s most notorious asymptomatic carrier, and Senator Cory Booker reflects on political division in national crises.John Prideaux, The Economist’s US editor, hosts with Charlotte Howard, New York bureau chief, and Washington correspondent Jon Fasman.Read The Economist’s full coverage of the coronavirus.For access to The Economist’s print, digital and audio editions subscribe: www.economist.com/pod2020.  See acast.com/privacy for privacy and opt-out information.

President Trump changed tone and course this week, extending federal guidelines on social distancing to the end of April. New York is now the epicentre of the global pandemic. Yet large parts of the US remain relatively unaffected by covid-19. Public opinion supports tough measures to contain the virus for now. But how sustainable are strict curbs on personal freedom in a country founded on individual liberty?The Economist’s healthcare correspondent Slavea Chankova explains the epidemiological models behind the lockdown, we tell the story of history’s most notorious asymptomatic carrier, and Senator Cory Booker reflects on political division in national crises.John Prideaux, The Economist’s US editor, hosts with Charlotte Howard, New York bureau chief, and Washington correspondent Jon Fasman.Read The Economist’s full coverage of the coronavirus.For access to The Economist’s print, digital and audio editions subscribe: www.economist.com/pod2020. See acast.com/privacy for privacy and opt-out information.

Covid-19, the new coronavirus, is spreading around the world. Abdi Mahamad, the World Health Organisation’s incident manager for Asia, reveals that for the first time since the start of the outbreak, more cases are being reported outside China than within it. What can countries do to limit the spread of the virus, and will it become a pandemic? The Economist’s deputy editor Tom Standage hosts a debate with Therese Hesketh, professor of global health at the Institute for Global Health at University College London; Christl Donnelly, professor of statistical epidemiology at Imperial College London a WHO Collaborating Centre for Infectious Disease Modelling; and Slavea Chankova, our health-care correspondent. Please subscribe to The Economist for full access to print, digital and audio editions:www.economist.com/radiooffer See acast.com/privacy for privacy and opt-out information.

Covid-19, the new coronavirus, is spreading around the world. Abdi Mahamad, the World Health Organisation’s incident manager for Asia, reveals that for the first time since the start of the outbreak, more cases are being reported outside China than within it. What can countries do to limit the spread of the virus, and will it become a pandemic? The Economist’s deputy editor Tom Standage hosts a debate with Therese Hesketh, professor of global health at the Institute for Global Health at University College London; Christl Donnelly, professor of statistical epidemiology at Imperial College London a WHO Collaborating Centre for Infectious Disease Modelling; and Slavea Chankova, our health-care correspondent. Please subscribe to The Economist for full access to print, digital and audio editions:www.economist.com/radiooffer See acast.com/privacy for privacy and opt-out information.

A 2016 education report from The Economist asks if higher wages or less working hours make a better teacher. While South Korea has one of the highest wages for public teachers in the OECD, public teachers in the ROK also spend double the average amount of time on administrative tasks. Korea FM reporter Chance Dorland spoke with Economist data journalist Slavea Chankova & Ellen Sherratt, the co-Deputy Director of the Center on Great Teachers & Leaders & senior researcher at American Institutes for Research, to find out more. Find more info on teacher pay vs work hours at http://www.economist.com/blogs/graphicdetail/2016/04/daily-chart-18Stream this episode online at http://www.spreaker.com/user/seoulitup/teacher-pay-vs-work-hours-which-is-betteDownload the full episode at http://api.spreaker.com/download/episode/12053823/south_korean_teacher_pay_working_hours_korea_fm.mp3Rate & Review this podcast at http://bit.ly/KFMReviewThis episode is brought to you by Podcast Assist & its $30 per hour flat rate podcasting voice overs, editing, mastering, transcriptions & even hosting (select a topic, they'll create & host the podcast). Visit Facebook.com/PodcastAssist for more information.Subscribe to this & other Korea FM original content via:iTunes - http://apple.co/1O91B39Overcast - http://bit.ly/KFMovercastRSS - http://bit.ly/KFMfeedStitcher - http://bit.ly/KFMstitcherPlayer FM - http://bit.ly/KFMplayerfmTunein - http://bit.ly/KFMtuneinAcast - http://bit.ly/KFMacast

A 2016 education report from The Economist asks if higher wages or less working hours make a better teacher. While South Korea has one of the highest wages for public teachers in the OECD, public teachers in the ROK also spend double the average amount of time on administrative tasks. Korea FM reporter Chance Dorland spoke with Economist data journalist Slavea Chankova & Ellen Sherratt, the co-Deputy Director of the Center on Great Teachers & Leaders & senior researcher at American Institutes for Research, to find out more. Find more info on teacher pay vs work hours at http://www.economist.com/blogs/graphicdetail/2016/04/daily-chart-18Stream this episode online at http://www.spreaker.com/user/seoulitup/teacher-pay-vs-work-hours-which-is-betteDownload the full episode at http://api.spreaker.com/download/episode/12053823/south_korean_teacher_pay_working_hours_korea_fm.mp3Rate & Review this podcast at http://bit.ly/KFMReviewThis episode is brought to you by Podcast Assist & its $30 per hour flat rate podcasting voice overs, editing, mastering, transcriptions & even hosting (select a topic, they'll create & host the podcast). Visit Facebook.com/PodcastAssist for more information.Subscribe to this & other Korea FM original content via:iTunes - http://apple.co/1O91B39Overcast - http://bit.ly/KFMovercastRSS - http://bit.ly/KFMfeedStitcher - http://bit.ly/KFMstitcherPlayer FM - http://bit.ly/KFMplayerfmTunein - http://bit.ly/KFMtuneinAcast - http://bit.ly/KFMacast

Should disease-bearing mosquitoes be made extinct? Natasha Loder lays out the arguments for using gene drives to do so. We hear an update on the known unknowns of the Zika virus from Slavea Chankova and whether “feed a fever, starve a cold” is sound advice. Jason Palmer hosts. See acast.com/privacy for privacy and opt-out information.

Should disease-bearing mosquitoes be made extinct? Natasha Loder lays out the arguments for using gene drives to do so. We hear an update on the known unknowns of the Zika virus from Slavea Chankova and whether “feed a fever, starve a cold” is sound advice. Jason Palmer hosts. See acast.com/privacy for privacy and opt-out information.